Genmab to buy back 370,000 shares
![Jan van de Winkel, CEO of Genmab | Photo: PR / Genmab](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14161079.ece/ALTERNATES/schema-16_9/doc7lh69wbp79vbvvzccx3.jpg)
A total of 370,000 Genmab shares will be repurchased by the biotech firm itself, according to a company press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Analyst: Genmab cancer data is promising compared to rival
For subscribers
Genmab presents full data set for cancer drug
For subscribers